Dupilumab: Mechanism of action, clinical, and translational science.
Saved in:
| Title: | Dupilumab: Mechanism of action, clinical, and translational science. |
|---|---|
| Authors: | McCann MR; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Xu C; Sanofi, Bridgewater, New Jersey, USA., Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Kamal MA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e13899. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39080841 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dupilumab: Mechanism of action, clinical, and translational science. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McCann+MR%22">McCann MR</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kosloski+MP%22">Kosloski MP</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Xu+C%22">Xu C</searchLink>; Sanofi, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Davis+JD%22">Davis JD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kamal+MA%22">Kamal MA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e13899. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39080841 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cts.13899 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e13899 Titles: – TitleFull: Dupilumab: Mechanism of action, clinical, and translational science. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McCann MR – PersonEntity: Name: NameFull: Kosloski MP – PersonEntity: Name: NameFull: Xu C – PersonEntity: Name: NameFull: Davis JD – PersonEntity: Name: NameFull: Kamal MA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1752-8062 Numbering: – Type: volume Value: 17 – Type: issue Value: 8 Titles: – TitleFull: Clinical and translational science Type: main |
| ResultId | 1 |
